Skip to main content
Research CombinationRecoveryEmerging EvidenceEducational · Not medical advice

BPC-157 + TB-500: Tissue Repair & Recovery

A widely used injury recovery stack combining BPC-157's potent localised tissue healing with TB-500's systemic cell migration and angiogenesis support via thymosin beta-4 activity. BPC-157 focuses on tendon, ligament, and gut repair through growth factor receptor upregulation, while TB-500 accelerates broader tissue repair and reduces inflammation. The two peptides address complementary steps in the healing cascade with minimal mechanistic overlap.

2
Compounds
Emerging
Evidence Level
3
Research Refs
Recovery
Primary Goal

Mechanism

Compound 1Recovery

BPC-157

Drives localised tissue repair by upregulating growth factor receptors (VEGF, EGF) and promoting angiogenesis at injury sites, with robust efficacy across tendon, ligament, muscle, and gut tissue in animal research.

+
Compound 2Recovery

TB-500

Promotes systemic tissue repair and cell migration by upregulating actin polymerisation and reducing local inflammation, complementing BPC-157's localised signalling with broader, circulating repair activity.

Synergistic Effect

Dual-pathway activation

BPC-157 × TB-500

Safety Notes

Both are unapproved research compounds; BPC-157 is available through some 503A compounding pharmacies for investigational use. Animal studies suggest pro-angiogenic properties — individuals with active malignancy or a history of cancer should consult a physician before use. Human clinical data for both compounds is limited, particularly for this combination. Neither is approved for use in competitive sports governed by WADA.

Research References

Emerging

Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157

Curr Pharm Des 2013PMID 23127660
Emerging

Thymosin β4: a multi-functional regenerative peptide

Expert Opin Biol Ther 2012PMID 22335423
Emerging

Novel aspects of the cytoskeletal role of thymosin-beta4

FASEB J 2001PMID 11500374
Browse all →

⚠ Educational Use OnlyPeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.